European K-Shaped Recovery 2026: Europe is not experiencing a conventional recovery. What appears, at an aggregate level, to be modest and stabilising growth is in fact the result of two fundamentally different demand patterns moving in opposite directions. This divergence has been described as a K-shaped recovery, but the label understates the strategic implications. The […]
The Inflationary Mask: Why Stable Revenue is Hiding a Structural Reset Most FMCG companies are entering 2026 with the same problem, even if their numbers still look acceptable. Revenue is holding. Margins are under control. Pricing has done its job. And yet, something is clearly breaking. The last three years created a distorted view of […]
The Poppi Myth: Why Systems, Not Spikes, Built a $2B Functional Soda Brand Poppi is often presented as a textbook example of how modern consumer brands grow. The story is usually told in a sequence of standout moments: a founder discovers a functional health benefit, a television appearance brings in a well-known investor, social media […]
The Newness Machine: Why SKU Proliferation is Killing Long-Term Brand Equity Most brand teams aren’t building brands anymore. They’re feeding a pipeline. Across food and beverage, especially in large multinational portfolios, the pattern is consistent. Every year brings a wave of collaborations, limited editions, and cross-brand extensions. New flavours, new formats, new co-branded SKUs. Most […]
Explore the key performance trends and strategies shaping the global beverage sector in 2025-2026, focusing on premiumisation and market dynamics.
Insights into The Magnum Ice Cream Company’s performance post-demerger, highlighting growth strategies and market challenges in FY 2025.
Explore Ahold Delhaize’s 2025 results and their implications for the retail landscape, focusing on profitability, strategic pivots, and market trends.
Explore Coca-Cola’s 2025 performance and 2026 strategy as it navigates market shifts and embraces digital transformation.
Explore Kirin Holdings’ divestiture of Four Roses and its pivot to health sciences amid a cooling bourbon market.